Streetbeat News

Stock Prices

RVNC

Revance Therapeutics' stock price increased following the announcement of their Q4 financial results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 7:03 pm

HBARUSD

Hedera (CRYPTO: HBAR) has seen a price increase of 6.1% in the last 24 hours, reaching $0.12, despite a 1.0% loss over the past week. Its all-time high is $0.57. Trading volume has decreased by 13.0%, and the circulating supply has slightly decreased to 33.69 billion, which is 67.37% of its max supply. HBAR's market cap ranks it #34 at $3.88 billion.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 7:03 pm

ETSY

Significant options trading activity on Etsy (NASDAQ:ETSY) indicates a mixed sentiment among big-money investors, with a lean towards bearishness. Benzinga's options scanner revealed 9 unusual trades, showing a split sentiment of 44% bullish and 55% bearish. The trades focus on a price band between $60.0 and $90.0 for Etsy. Analysts have varying views on Etsy, with target prices ranging from $64 to $95. The company, a major e-commerce marketplace, reported a consolidated gross merchandise volume of $13.2 billion in 2023.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 7:02 pm

MIRM

Mirum Pharmaceuticals (NASDAQ:MIRM) has received mixed analyst ratings over the last quarter, with a shift towards a more cautious outlook. The average 12-month price target has been adjusted to $55.25, down from $69.00, indicating a 19.93% decrease. Analysts from firms like Cantor Fitzgerald, JMP Securities, Raymond James, and HC Wainwright & Co. have provided updates, with some maintaining their ratings and others lowering their price targets. Mirum Pharmaceuticals, a biopharmaceutical company, focuses on therapies for rare diseases and has shown significant revenue growth and a strong market presence, despite challenges in debt management and return on equity.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 7:02 pm

ATOMUSD

Cosmos Hub (CRYPTO: ATOM) has seen a significant price increase of 5.08% in the last 24 hours, reaching $11.73, with a weekly gain of over 17% from $9.92. The cryptocurrency's trading volume surged by 54% over the week, while its circulating supply rose by 0.46% to 388.48 million. Currently, ATOM's market cap ranks it 24th at $4.53 billion.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 7:01 pm

STEM

Stem (NYSE:STEM) has received mixed analyst ratings over the past three months, with a shift towards a more cautious outlook. The average 12-month price target for STEM has been lowered to $4.05, indicating a 26.36% decrease from the previous target of $5.50. Analysts from firms including Susquehanna, Piper Sandler, BMO Capital, Goldman Sachs, and Morgan Stanley have all adjusted their ratings and price targets downwards, reflecting concerns over market conditions and company performance. Despite this, Stem's financials show a positive revenue trend with a growth rate of 34.41% as of September 30, 2023, but challenges in net margin, ROE, ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 7:00 pm

IMO

Imperial Oil (AMEX:IMO) has outperformed the market with an average annual return of 18.36% over the past 5 years, growing a $100 investment to $230.90. The company's market capitalization stands at $33.71 billion.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 7:00 pm

UNH

UnitedHealth Group (NYSE:UNH) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target for UNH is $583.22, slightly up from the previous $583.00. Analysts from firms like RBC Capital, Stephens & Co., Cantor Fitzgerald, Oppenheimer, Piper Sandler, and HSBC have maintained or adjusted their ratings and price targets, reflecting their views on the company's market position and financial health. UnitedHealth Group, a leading private health insurer, has shown strong financial performance with notable revenue growth, net margin, ROE, and ROA, despite a higher debt-to-equity ratio compared to industry averages.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 7:00 pm

FILUSD

Cryptocurrency Filecoin (FIL) has seen a significant price increase of 13.55% in the last 24 hours, reaching $8.48. Over the past week, FIL's price has risen over 3.0%, from $8.38. The coin's all-time high is $236.84. Trading volume for FIL has increased by 10.0% over the past week, and its circulating supply has grown by 0.71% to over 516.06 million, representing approximately 26.32% of its maximum supply of 1.96 billion. Filecoin's market cap ranking is currently #28, with a valuation of $4.39 billion.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 7:00 pm

AUMN

BFLY

ENVB

JL

SCTL

Butterfly Network, Inc. (BFLY) shares fell by 22% after reporting a larger-than-expected GAAP loss for Q4, despite beating sales estimates. Other stocks experienced significant movements, with Enveric Biosciences, Inc. (ENVB) and Societal CDMO, Inc. (SCTL) among the top gainers, while J-Long Group Limited (JL) and Golden Minerals Company (AUMN) led the losers.

Portfolio Pulse from Avi Kapoor

February 29, 2024 | 7:00 pm